The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

医学 麻醉 胃肠病学 安慰剂 随机对照试验 入射(几何) 内科学 外科 谵妄 甲基强的松龙 病理 光学 物理 重症监护医学 替代医学
作者
Xiaobing Xiang,Hao Chen,Yingli Wu,Ke Wang,Yue Xiang,Xinqi Cheng
出处
期刊:The Journals of Gerontology [Oxford University Press]
卷期号:77 (3): 517-523 被引量:13
标识
DOI:10.1093/gerona/glab248
摘要

Preoperative administration of methylprednisolone reduced circulating markers of endothelial activation. This randomized, double-blind, placebo-controlled trial was to evaluate whether a single preoperative dose of methylprednisolone reduced the rate of postoperative delirium (POD) in older patients undergoing gastrointestinal surgery and its association with the shedding of endothelial glycocalyx markers.About 168 patients, aged 65-80 years and scheduled for laparoscopic gastrointestinal surgery, were randomized to 2 mg/kg methylprednisolone (Group M, n = 84) or equivalent dose of placebo (Group C, n = 84). The primary outcome was the incidence of delirium during the first 5 days after surgery, assessed by the Confusion Assessment Method (CAM). POD severity was rated daily using CAM-Severity (CAM-S). Levels of syndecan-1, heparan sulfate, tumor necrosis factor-α (TNF-α), and brain-derived neurotrophic factor (BDNF) were measured at baseline, 1 day, and 3 days after surgery.Compared with placebo, methylprednisolone greatly reduced the incidence of delirium at 72 hours following surgery (9 [10.7%] vs 20 [23.8%], p = .03, OR = 2.22 [95% CI 1.05-4.59]). No between-group difference was found in the cumulative CAM-S score (p = .14). The levels of heparan sulfate, syndecan-1, and TNF-α in Group M were lower than that in Group C (p < .05 and p < .01), while the level of BDNF in Group M was higher than that in Group C (p < .01).Preoperative administration of methylprednisolone does not reduce the severity of POD, but may reduce the incidence of delirium after gastrointestinal surgery in older patients, which may be related to a reduction in circulating markers of endothelial degradation, followed by the increase of BDNF level.Chinese Clinical Trial.gov, ChiCTR2000028792. Registered January 4, 2020. http://www.chictr.org.cn/showproj.aspx?proj=47807.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Uuup完成签到 ,获得积分20
1秒前
sjandljw发布了新的文献求助10
2秒前
科研通AI6.4的应助被tomatoGG采纳,获得10
2秒前
滴滴答答发布了新的文献求助10
2秒前
Bella完成签到,获得积分20
2秒前
科研通AI6.4的应助被040采纳,获得30
3秒前
PP关闭了PP的文献求助
3秒前
3秒前
3秒前
zhaohuiblbl完成签到,获得积分10
3秒前
安徒完成签到,获得积分10
3秒前
4秒前
小蘑菇的应助被自信芝麻采纳,获得20
4秒前
完美的诗云完成签到,获得积分20
4秒前
ding的应助被生生采纳,获得10
4秒前
4秒前
斯文败类的应助被db采纳,获得10
4秒前
5秒前
岚岛发布了新的文献求助10
5秒前
所所的应助被SS采纳,获得10
5秒前
5秒前
阳光以山完成签到 ,获得积分10
5秒前
华仔的应助被Dssaadji采纳,获得10
5秒前
124536完成签到,获得积分10
6秒前
6秒前
Nano完成签到,获得积分10
6秒前
xiaochen发布了新的文献求助10
7秒前
英俊的铭的应助被背后尔容采纳,获得10
7秒前
花果山光腚猴完成签到,获得积分10
8秒前
阔达凝雁完成签到,获得积分10
9秒前
溪夕er完成签到,获得积分10
9秒前
一一发布了新的文献求助10
9秒前
www发布了新的文献求助10
9秒前
10秒前
11秒前
滴滴答答发布了新的文献求助10
11秒前
李博源完成签到,获得积分20
12秒前
高宇晖完成签到,获得积分10
12秒前
13秒前
天天快乐的应助被wanghao采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Erzählte Gnade 500
Butadiene hydroxytelechelic oligomers PBHT 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8082904
求助须知:如何正确求助?哪些是违规求助? 9498094
关于积分的说明 21405101
捐赠科研通 7651038
什么是DOI,文献DOI怎么找? 3402032
关于科研通互助平台的介绍 2531101
邀请新用户注册赠送积分活动 2440672